- Dark and Lovely lawsuits have been consolidated in multidistrict litigation (MDL 3060) and a class action lawsuit. The claims in each are different.
- L’Oréal is being accused of failing to warn users of Dark and Lovely hair relaxer products of the harms associated, while negligently marketing them as safe and beneficial.
- The plaintiffs allege that the chemicals in Dark and Lovely hair relaxer are toxic and cause endometrial cancer, ovarian cancer and uterine cancer.
Active case
Case Overview
L’Oréal is facing lawsuits for its Dark and Lovely hair relaxer. Studies have connected chemicals in hair relaxer products like Dark and Lovely to an increased risk of ovarian cancer, uterine cancer and endometrial cancer. People affected by these cancers are filing Dark and Lovely lawsuits alleging the product caused their disease. Plaintiffs claim that defendants engaged in problematic marketing which failed to disclose the serious health risks posed to consumers.
Key takeaways about the Dark and Lovely lawsuit
L’Oréal Dark and Lovely
L’Oréal’s Dark and Lovely brand, typically stylized as Dark & Lovely, markets its hair products to Black and Brown women. Their product lines include chemical-based permanent hair relaxers. Dark & Lovely hair relaxer products are used to straighten and smooth naturally textured hair.
Black women in the United States have been using hair relaxers for generations. Historically, textured hair has been stigmatized as inconsistent with Euro-centric standards of beauty. Texturism — the idea that “good hair” is straighter hair — has deep-seated roots in American history.
Inventor Garrett Augustus Morgan created and marketed the first chemical-based system for permanent hair straightening in the early 1900s. Popular brand Dark & Lovely launched in the 1970s.
Overview of the Dark and Lovely lawsuit
All individual lawsuits that make similar claims against Dark & Lovely are centralized into one multidistrict litigation (MDL) in the Northern District of Illinois. The lawsuits in MDL 3060, In re: Hair Relaxer Marketing Sales Practices And Products Liability Litigation include allegations against L’Oréal and other hair straightening manufacturers. Separately, a class action lawsuit has also been filed.
The MDL and class action lawsuit claim the defendants:
- Perpetuated biased messaging about having straight hair
- Designed an unreasonably dangerous product
- Promoted their hair relaxer products without proper warnings about health risks, while presenting them as “safe.”
MDL and class action lawsuits are both ways of grouping together similar claims. However, there are several differences between the two, including:
- Federal MDL cases are handled in federal courts. Class action lawsuits can be filed in state or federal court.
- All plaintiffs in MDLs retain their own case. In a class action lawsuit, one or more plaintiffs file a single lawsuit representing a group of injured parties (the class).
- Cases in an MDL may be resolved individually. A class action lawsuit may result in a single resolution for all class members.
What is the status of the Dark and Lovely lawsuit?
Thousands of hair relaxer lawsuits are proceeding in federal court in an MDL. The MDL consolidates the allegations against hair relaxer manufacturers, including L’Oréal. As of mid-2024, over 8,000 actions were pending in the hair relaxer MDL.
Can you join a L’Oréal hair relaxer lawsuit?
You may be able to file a L’Oréal hair relaxer lawsuit if you or a loved one used L’Oréal chemical hair relaxers and developed ovarian cancer, uterine cancer or endometrial cancer.
Contact a hair relaxer lawyer
If you or a loved one were diagnosed with ovarian, uterine, or endometrial cancer after using a chemical hair relaxer product, you are not alone during this challenging time. For more information or to discuss a potential claim, reach out to hair relaxer MDL co-lead Fidelma Fitzpatrick or Tope Leyimu. Call 1.800.768.4026 or via email at any time.
L’Oréal’s product promotion of Dark and Lovely
For over 50 years, L’Oréal has advertised hair relaxer products to customers across the U.S. and around the world. The marketing failed to warn of the harmful impacts associated with their products, instead reinforcing notions of straight hair as a beauty standard and negligently marketing these products as safe.
U.S. cosmetics laws forbid the marketing of “adulterated” or “misbranded” products. Adulteration refers to products containing substances that could harm the user’s health. Misbranding means wrongly or dishonestly labeled products. It is also illegal to include an ingredient in a cosmetic product that makes the product harmful when people use it as intended.
Is Dark and Lovely hair relaxer safe?
The lawsuit alleges Dark & Lovely hair relaxers contain dangerous chemicals that may make them unsafe. Long-term use of hair relaxers with certain endocrine-disrupting chemicals have been linked to cancer.
Endocrine-disrupting chemicals (EDCs) interrupt the natural function of the endocrine system. The endocrine system regulates things like hormones release, reproductive health, growth and development. A change in hormone levels can lead to severe health issues including:
- Cognitive deficits
- Endometrial, ovarian and uterine cancer
- Immune disorders
- Infertility
- Metabolic syndrome
- Reproductive impairment
L’Oréal lawsuits allege that the company did not warn consumers of the increased risks of these conditions. It also didn’t make them aware of the lack of testing for safety risks like ovarian cancer and uterine cancer.
Hair straighteners can also cause burns and lesions in the scalp. These wounds allow the chemicals in hair relaxers to enter the body. It is alleged that certain chemicals in hair straighteners and relaxers may increase the risk of cancer in women.
Does Dark and Lovely cause cancer?
Plaintiffs allege frequent use of Dark & Lovely chemical hair relaxers cause cancer. Multiple studies show that women who use chemical hair relaxers have a higher risk of uterine cancer than those who do not.
Plaintiffs are filing lawsuits against L’Oréal, the maker of Dark & Lovely. The cases allege L’Oreal had a duty to assure its products would not cause users to suffer unreasonable and dangerous side effects, such as cancer.
Uterine and endometrial cancer
Research has shown that frequent hair relaxer use may lead to uterine and endometrial cancer. One study concluded that women who used hair straightening products more than four times in the previous year were over twice as likely to develop uterine cancer compared to women who did not use the products. Approximately 60% of the women in the study who used straighteners or relaxers were Black.
Consumers of hair relaxer products who have suffered uterine cancer often require hysterectomies. Many plaintiffs can no longer have children – an extremely painful loss.
Ovarian cancer
The Sister Study also found an association between frequent use of hair relaxers and ovarian cancer. Like uterine cancer, ovarian cancer is also believed to be hormonally driven. This means when hormone-disrupting compounds enter the body, they disturb a woman’s hormonal balance, which could lead to ovarian cancer.
Black and Brown women are more likely to encounter ovarian cancer risks linked with using those products. This is because they are the overwhelming majority of consumers of hair relaxer products.
Our experience litigating defective products that harm women
Motley Rice leads litigation brought by thousands of women harmed by defective products. Our law firm has extensive experience litigating product liability lawsuits for women who:
- Developed ovarian cancer after using talc-based baby powder for feminine hygiene
- Suffered breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) allegedly caused by Allergan implants
- Endured severe complications allegedly caused by birth control devices such as Essure® and Paragard® and complications arising from the use of transvaginal mesh
Many people have been impacted by ovarian cancer, uterine cancer or endometrial cancer allegedly caused by using chemical hair relaxers. If you believe you have been similarly harmed, you should consider discussing your options with an attorney with experience in multidistrict litigation (MDL) and class actions.
L’Oréal Dark and Lovely background info
Overview of the Dark and Lovely lawsuit
L’Oréal’s product promotion of Dark and Lovely
Is Dark and Lovely hair relaxer safe?
Does Dark and Lovely cause cancer?
Our experience litigating defective products that harm women
Sources
- ABA. MDL vs. Class Action: Place, Plaintiffs, and Procedure.
- Chang CJ, et al. Use of Straighteners and Other Hair Products and Incident Uterine Cancer. Journal of the National Cancer Institute, Oct., 17, 2022.
- DTSC. Chemicals in Hair Straightening Products.
- Harley KG, et al. Reducing phthalate, paraben, and phenol exposure from personal care products in adolescent girls: findings from the HERMOSA Intervention Study. Environ Health Perspect 2016;124:1600–1607.
- Helm J.S., et al. Measurement of endocrine disrupting and asthma-associated chemicals in hair products used by Black women. Environ. Research 2018;165:448-458.
- Koski O, Hu S. Fighting Phthalates. National Resources Defense Council, April 20, 2022.
- Mallozzi M, et al. Endocrine disrupting chemicals and endometrial cancer: an overview of recent laboratory evidence and epidemiological studies. Int J Environ Res Public Health. 2017 Mar 22;14(3):334.
- Mamavation. Hair Relaxer Products: When Racism & Toxins Collide.
- Mayo Clinic. Metabolic syndrome.
- Medical News Today. How does bisphenol A affect health?
- Odele. 6 Things Everyone Should Know About Black Hair History.
- Peterson, Jaclyn. The Price of Beauty. CTI Charlotte Teachers Institute Curriculum (2021).
- Pierce J.S., et al. Characterization of Formaldehyde Exposure Resulting from the Use of Four Professional Hair Straightening Products. J. Occ. and Environ. Hygiene 2011;8:686-699.
- Randle, B. I Am Not My Hair, Race, Gender and Class. Volume 22, Number 1-2, 114 121 (2015).
- Richard, C. This History of Hair Relaxers.
- Sarink D, et al. BPA, parabens, and phthalates in relation to endometrial cancer risk: a case-control study nested in the multiethnic cohort. Environ Health Perspect. 2021;129(5):57702.
- United States Environmental Protection Agency. Endocrine Disruption.
- U.S. Centers for Disease Control and Prevention. Fourth national report on human exposure to environmental chemicals: updated tables, Volume 1.
- Wang Y, Qian H. Phthalates and Their Impacts on Human Health, Healthcare. 2021 May; 9(5): 603.
- White, AJ, Sandler DP, Gaston SA, Jackson CL, O'Brien KM. Use of Hair Products in Relation to Ovarian Cancer Risk. Carcinogenesis. Vol. 42, No. 9, 1189-1195, 1189 (2021).
- Wise, L.A. et al. Epidemiology of Uterine Fibroids – From Menarche to Menopause. Clin Obstet Gynecol. 2016;59(1):2-24.
- U.S. Food and Drug Administration. Prohibited & Restricted Ingredients in Cosmetics.
- Zota A.R., et al. The Environmental Injustice of Beauty: Framing Chemical Exposures from Beauty Products as a Health Disparities Concern. Am. J. Obstet. & Gyn. Oct. 2017.
1
Submit
Information
Call us or fill out our online form with your case details.
2
Case
Review
Our team meticulously reviews your information to assess your case's potential.
3
Case
Consultation
Discuss next steps with our lawyer for tailored guidance.